CurveBeam Connect: How Legislators Got On Board with Cone Beam CT

 

Belgian surgeons were beginning to utilize cone beam CT several years ago.

Then, doctors like AZ Groeninge Kortrijk’s Dr. Frederik Vanrietvelde suddenly had to slow their use of the modality because of price concerns, with cone beam CT suddenly left off a crucial list made by legislators.

Vanrietvelde and some colleagues lobbied to make sure it was included, noting that it met the definition of a CT scan approved for reimbursement by the government and that its absence was simply a mistake.

“If you look very closely, you could tell cone beam CT also corresponds to these particular parameters they use, so it should have been on this list, anyway,” he said. “So, there was really no reason why it shouldn’t be on the list, and they really never argued that what we were asking was not correct. They simply said, ‘Sorry, we forgot it. We have to correct it.’”

Even still, the process took two years for hospitals to once again be able to bill cone beam CT in the same way they were billing a more traditional CT scan. With that being the case, the numbers of Belgian doctors utilizing the technology remain relatively small.

Still, Vanrietvelde is confident their numbers will grow now that the scans are more accessible, and he said the most important thing was to put himself into others’ shoes.

“It’s always a difficult balance you have to do as a legislator. I’m thinking as a radiologist, and the patient is thinking as a patient. A legislator has to think as a legislator and think about budget balance, so my main advice would be come together,” he said. “Let’s get all those people together with different mindsets and different perspectives before you decide how to reimburse something.”

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Recent Episodes

Healthcare is being pushed to modernize faster than ever, as AI tools, virtual care, and digital patient experiences shift from innovation to expectation. Recent survey data from McKinsey & Company indicates that about half of U.S. healthcare leaders say their organizations have already put generative AI into practice, underscoring how quickly the technology is…

Heart disease remains the leading cause of death in the U.S., with 683,491 deaths reported in 2024, according to the CDC. As cardiovascular care shifts toward access, prevention, and value-based outcomes, noninvasive therapies are gaining renewed attention for patients who continue to experience symptoms after traditional interventions. At the same time, rising healthcare costs…

Healthcare leadership is being redefined in real time. With the rise of AI, mounting financial pressures, and workforce burnout, executives today are operating in an environment of continuous disruption and uncertainty. In fact, industry leaders now rank workforce shortages and digital transformation among their top concerns—forcing a new kind of leadership that blends decisiveness…